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ELUCIDATION OF THE PATHWAY REQUIRED FOR THE STIMULATION
OF G6PDH GENE EXPRESSION BY INSULIN AND ITS MIMETICS

Asavari Wagle, M.A.
Western Michigan University, 1997
Insulin, an anabolic hormone, exquisitely controls cellular physiology and
metabolism by modulating the activity of key proteins which regulate metabolic and
mitogenic events. Insulin activates several cytosolic proteins via a phosphorylation
cascade, but only some of these proteins are required for its specific action. We have
elucidated the insulin signal transduction cascade in primary rat hepatocytes, and
outlined some of the events that are required for the insulin induced stimulation of
glucose-6-phosphate dehydrogenase (G6PDH) gene expression.

Using well-

characterized and structurally different inhibitors, we show that insulin stimulation of
the gene requires the IRS-1/PBK pathway and not the RAS/RAF/MAPK pathway.
Gene expression is dependent on S6Kinase, which is controlled by PBK and as our
results suggest, by Akt. Since previous studies have shown that the insulin mimetics,
selenate and vanadate, control G6PDH gene expression, we studied the effect of these
mimetics on the signaling proteins. Our results are consistent with the properties of
vanadate as a phosphatase inhibitor. On the other hand, selenium signal transduction
appears to be sequential and similar to insulin in the regulation of some of the proteins
in the cascade.
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CHAPTER I
INTRODUCTION
Insulin
Insulin is a potent anabolic hormone, important in the regulation of a wide
variety of metabolic events. It is secreted in the � cells of the pancreas in response to
increased blood glucose concentration. In primary target tissues, liver, muscle and
adipose, it is responsible for the influx of nutrients into the cells, synthesis and storage
of carbohydrates, lipids and proteins. The hormone modulates the rates of DNA,
RNA and protein synthesis and cellular growth and differentiation (White et al). It
also regulates the expression of key metabolic enzymes like phosphoenolpyruvate
carboxykinase (PEPCK), glycogen synthase and fatty acid synthase (FAS).
Lack of insulin or failure to respond to insulin causes the disease Diabetes
mellitus which is normally classified into two types, Type-I or IDDM (Lernmark A)
and Type-2 or NIDDM (Degroot L.J.), respectively. Both diseases are characterized
by increased blood glucose concentrations which leads to further complications.
The broad spectrum of tissue specific responses generated by insulin can only
be accounted for by a complex regulatory mechanism. Early on, investigators believed
that the insulin signal was relayed via cyclic nucleotides and ion channels but as
research continued, protein phosphorylation gained more significance and emerged as
the molecular mechanism responsible for the varied actions of insulin (Avruch et al).
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Insulin Signal Transduction
Insulin exerts its control on organismal and cellular physiology by activating
several intracellular phosphorylation signals, generating a phosphorylation cascade
(Figure 1).
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Figure 1. Insulin Signal Transduction Cascade.
Insulin action is initiated at the cell surface receptor where binding to the
receptor activates all downstream proteins.

The insulin receptor is an

3
autophosphorylating tyrosine kinase (Kasuga et al).

Its a-subunits, which are

completely extracellular, bind to the hormone and lead to the phosphorylation of
several tyrosine residues of the intracellular P-subunit (Ullrich et al).

Tyrosine

phosphorylation of the receptor is necessary for the full expression of the receptor
kinase activity (White et al) which is responsible for phosphorylation and activation of
downstream proteins
One of the immediate downstream proteins (Figure 1), first characterized and
cloned from rat liver cells, was the 185 K-Da protein, Insulin Receptor Substrate-I
(IRS-1) (Rothenberg et al).

This protein has several potential tyrosine

phosphorylation sites in the C-terminus and at least eight are phosphorylated in
response to insulin (Sun et al).

Apart from this region, which contains multiple

tyrosine residues, IRS-1 also contains characteristic motifs which provide binding sites
for downstream proteins bearing src homology-2 (SH2) domains (Sun et al).
Another known substrate of the insulin receptor is She (Figure 1), a product of
the she gene.

The phosphotyrosine binding (PTB) domain of She is highly

homologous to that of IRS-1 suggesting that the insulin receptor engages the two
proteins in a similar fashion (Gustafson et al). She also contains several SH2 domains
which can serve as binding sites for downstream proteins.
The proteins with SH2 domains thus serve as docking proteins and are termed
molecular switches for tyrosine kinases.

They make important contacts with the

phosphate groups on phosphorylated tyrosine residues (Waksman et al) and are
responsible for signal divergence in the cascade.

They have been shown to have

different affinities for receptors and substrates which is dependent on the primary
sequence surrounding the phosphotyrosine binding (PTB) domain (Songyang et al).
A protein downstream of IRS-1 in the cascade, is phosphatidylinositol 3-kinase
(

(PBK), as shown in Figure 1. It is a dimeric enzyme containing two subunits, one of

which is catalytic (p110) and the other regulatory (p85) (Carpenter & Buckworth).
The p85 subunit contains two SH2 domains which bind to the tyrosine phosphorylated
IRS-I (Myer's et al). A region between the two SH2 domains of p85, called the
interSH2 (iSH2) region, binds to the N-terminus of pl 10, resulting in the activation of
the catalytic subunit (Klippel et al). For pl 10 to be fully active, both SH2 domains in
p85 have to be fully occupied and hence insulin stimulation of PBK requires the
association with IRS-1 (Figure 2) (Backer et al).

Figure 2. Association of p85 of PBK With p 110 and IRS-I.
PBK, is:a dual specificity kinase, which can phosphorylate proteins on tyrosine
and serine/threonine residues and also use lipids as substrates (Dhand et al).
Activation of PBK is implicated in the regulation of a variety of metabolic and
mitogenic cellular processes (reviewed by Kapellar & Cantley). It is cited as being
required for DNA synthesis, cell growth and transformation, glucose transport, and
regulation of glycogen synthase in various cell types including adipocytes, L6
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myoblasts and CHO IR cells. Using constitutively active forms of PBK, Klippel et al
have shown that an active PBK is sufficient to induce a number of different pathways.
Activated PBK is targeted to the membrane where it phosphorylates its lipid substrate,
mainly inositol phosphate, on the 3 position of D-myoinositol ring (Whitman et al) to
yield mono, di and tri phosphate derivatives (Figure 3), namely, phosphatidylinositol3-phosphate, phosphatidylinositol-3,4-diphosphate and phosphatidylinositol-3,4,5triphosphate. These products can themselves act as second messengers and assist in
activating downstream events.
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Figure 3. Phosphatidylinositol and Its Phosphorylated Derivatives.
It was observed that the activity of PBK was accompanied by an increase in
intracellular levels of PI3,4P2 and PI3,4,5P3 which correlated with the efficiency of
PI3K to stimulate downstream responses such as cellular proliferation (Parker &

Waterfield), activation of Akt in COS-7 cells (Klippel et al), and other protein kinases
like protein kinase C in CHO IR cells (Toker et al).
A direct target of PBK is the serine/threonine kinase Akt (Franke et al).
Stimulation of the kinase activity of Akt is dependent on an activated PBK since
inhibitors of PBK also inhibit Akt kinase as shown by Burgering et al using NIB 3T3
cells stimulated by PDGF.

Cells containing dominant negative mutants of PBK

exhibited no akt kinase activity (Jones P. F.). The phosphorylation sites at the C
terminus and a pleckstrin homology (PH) domain at the N-terminus are required for
the activation of Akt while a central domain exhibits a high kinase activity (Franke et
al). Akt exists as a homodimer in the nonactivated state (Datta et el). When stimulated
by PDGF, the phospholipid products of PBK have been shown to bind to the PH
domain and activate Akt (Franke et al).

However, Kohn et al showed that the

association of the iSH2 region of PBK with Akt was essential for the phosphorylation
on serine/threonine residues, membrane targeting and the subsequent activation of Akt
by insulin while the PH domain was dispensable. One model which can explain the
controversy regarding activation of Akt is that phosphatidylinositol-3-phosphate
causes the dissociation of the inactive Akt homodimer and monomeric Akt is further
activated via phosphorylation by PBK (Bos, J.L.).

Alternatively, phospholipid

products of PBK may be necesary for recruiting Akt to the membrane where
membrane associated PBK phosphorylates and activates Akt. It is also possible that
insulin and PDGF have different mechanisms of action. The kinase activity of Akt is
associated with regulation of glycogen synthase activity, increased glucose transport in
3T3 Ll adipocytes and activation of S6Kinase (Burgering & Coffer).
Another downstream target of PBK is S6Kinase (Figure 1 ).

It

1s a

serine/threonine kinase responsible for phosphorylating and activating the 40S
ribosomal protein S6, which leads to stimulation of protein synthesis. S6Kinase can
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either be directly stimulated by PBK (Weng et al) or via Akt (Burgering & Coffer).
The exact mechanism of activation of S6Kinase by upstream kinases in not fully
defined. S6kinase activity can also be regulated by the kinase activity of rapamycin
sensitive FKBP12-rapamycin associated protein (FRAP) (Brown et al).
The above mentioned proteins, IRS- l/Pl3K/S6K form one branch ofthe insulin
signal transduction cascade. Alternatively, there exists a second branch originating
downstream ofShe and constitutes the proteins Ras/Raf/MEK/MAPK (Figure 1).
On being phosphorylated by the insulin receptor, IRS-1 and She compete for
association with the adaptor protein GRB-2 (growth factor receptor bound-2) (O'neill
et al), but recent research suggests that She is the major protein in this branch (Pronk
et al). The association of She with GRB-2 leads to the activation of son of sevenless
(SOS) protein which is a guanine nucleotide exchange factor. SOS promotes the
release of bound GDP from the protein RAS, the product of proto-oncogene ras,
which is activated upon GTP binding (reviewed by Seger & Krabs). Famesylation of
RAS targets it to the membrane, a process essential for further activations. Once
membrane bound, RAS interacts with the N-terminal region of Raf-1 (Matsuda et al),
a ser/thr kinase and recruits it to the membrane, a process which activates Raf-1
(Stokoe et al). On activation Raf-1 activates MAP kinase kinase (MEK). MEK is a
dual specificity kinase and is highly specific in the activation of map kinases ERK-1
and ERK-2 (Seger & Krebs), commonly called MAPKs. Phosphorylation of both
tyrosine and threonine residues ofMAPK is essential for the full expression ofenzyme
activity and for translocation into the nucleus. MAPKs can phosphorylate a wide
variety ofproteins, both in the cytoplasm as well as the nucleus. The main regulatory
proteins that are targets of MAPKs are nuclear transcription factors like elk-1, c-jun,
c-fos which mediate insulin induced gene expression (Davis, R). MAPKs are also
known to control protein synthesis via phosphorylation of PHAS-1. Interestingly,

MAPKs can also phosphorylate upstream proteins of the cascade like SOS, Raf-1 and
MEK to uncouple the SOS-GRB2 complex generating a feedback control on RAS
activation (Waters et al).
Elucidation of the Signal Pathway Necessary for
Induction of G6PDH Gene Expression
Signal transduction cascades can be elucidated by using certain chemical
compounds that are capable of inhibiting the enzyme activities of different proteins of
the cascade. Inhibitors have been used to determine the necessity of a particular
signal/protein in a signal transduction cascade. For example, the involvement of PBK
in cell trafficking (Kotani et al), glucose uptake and glycogen synthesis (Shepherd et
al) in various cell types, including 3T3 Ll adipocytes and CHO IR cells, was
determined using wortmannin, a fungal metabolite which is a well characterised
inhibitor of PBK. It inhibits PBK by inhibiting the association between PBK and
IRS-1 (Norman et al). Another inhibitor of PBK, LY 294002 has also been used to
prove the requirement of PBK for stimulation of S6Kinase, DNA synthesis and
glucose transporter translocation in 3T3 Ll adipocytes (Cheatham et al). LY 294002
is an analog of Quercetin and is structurally different from wortmannin (Vlahos et al).
It is a more specific inhibitor of PBK than wortmannin as it competes with p110 for
ATP binding.
The MEK inhibitor PD 098059, was used to analyse the MAPK pathway. The
inhibitor was used to show that MAPK is not involved in glucose utilization by insulin
in 3T3 1 fibroblasts and M6 myotubules (Lazar et al).

B581, a peptidomimetic

inhibitor is a tetrapeptide which mimics the CAAX tetrapeptide which is the
famesylation site of Ras (Garcia et al). By inhibiting Ras famesylation, B581 inhibits
membrane targeting which is responsible for downstream activations. Using B581,
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Ras has been shown to be differentially involved in the activation of MAPK in

adipocytes and fibroblasts (Whitehurst et al). An effective inhibitor of S6Kinase is
rapamycin, which on association with FRAP, inactivates S6K. Phosphorylation of S6K

on threonine 229 and 389 is important for the catalytic activity of S6K as it imparts a

negative charge to S6K, required for its functional activation. Rapamycin causes either
dephosphorylation or impaired phosphorylation of threonine 229 thus inhibiting S6K

activity (Sugiyama et al). Using wortmannin and rapamycin, Sutherland et al showed
that PBK but not S6K was required for the inhibition of PEPCK gene expression by
insulin.

Use of inhibitors has allowed insulin action with respect to glycolysis, TCA

cycle, lipogenesis and protein synthesis to be well characterized. Important enzymes

have been shown to be regulated in these processes, for example, glycogen synthase

kinase, PEPCK and fatty acid synthase. However, there has not been much effort to
study the action of insulin on the pentose phosphate pathway (PPP), an important

pathway that is responsible for the utilization of upto 60% of the glucose in the liver.

The Pentose phosphate pathway is important for generating pentose sugars and other

intermediates which are utilized for biosynthetic purposes. The reducing equivalence

generated in the form of NADPH is used for reductive biosynthesis of fatty acids and

for maintaining the redox state of the cell. The first enzyme of the pathway, Glucose-

6-phosphate dehydrogenase (G6PDH), is the key enzyme of the pathway. It converts

glucose-6-phosphate into its lactone, thereby generating a molecule of NADPH.
Glucose-6-PO

r

a-glucono-o-lactone

NADP+ ➔ NADPH
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Although constitutively expressed in most tissues, expression of G6PDH is
regulated in the liver, muscle and adipose tissue by insulin and other growth factors
(Kletzien et al). The expression of modulated amounts of G6PDH is crucial. The
hepatic enzyme activity changes as a result of insulin induced increase in gene
transcription, mRNA stability and rate of protein synthesis (Katsurada et al and Manos
et al). The mechanism by which insulin stimulates G6PDH gene expression has not yet
been characterized. Our laboratory has shown previously that insulin mimetics can
also induce G6PDH expression similarly to insulin (Berg et al) although the
mechanism of action has not been determined.
Insulin Mimetics
Insulin mimetics are chemical compounds or naturally occuring elements that
mimic the effects of insulin. Selenium and vanadium are two such essential trace
elements which have been known to exhibit insulin like properties. Vanadate, in
various oxidation states, has been proven to be a potent insulin mimetic and an anti
diabetic (Brichard et al) and is hence in a clinical trial for use as a therapy in NIDDM.
Selenate also has been shown to exhibit similar anti-diabetic potentials (Ezaki 0.).
Some of the well-known effects of these mimetic compounds are regulation of
glucose homeostasis. Vanadate lowers blood glucose concentration in vivo mainly by
channeling glucose into glycogen synthesis, which is accounted for by stimulation of
glycogen synthase (Clark et al). Selenate also decreases blood glucose levels in
streptozotocin (STZ) induced diabetic rats (Ezaki 0.). Both vanadate and selenate act
on muscle cells, adipocytes and hepatocytes. Vanadate increases the levels of fructose2,6-bisphosphate, stimulates glucokinase (Gil et al), G6PDH and pyruvate kinase
enzyme (Miralpeix et al) activity. Other in vitro effects of vanadate include inhibition
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of lipolysis in adipose tissue (Dubyak et al) and inhibition of gluconeogenesis in the
liver (Gil et al). Vanadate stimulates tyrosine phosphorylation of the kinase domains
of the insulin receptor in primary rat hepatocytes and 3T3 Ll adipocytes (Stapleton et
al). Selenate also stimulates the phosphorylation of the insulin receptor and IRS-1 in
rat primary hepatocytes and activates MAPK (Stapleton et al).
In addition to these effects on cell regulation, both selenate and vanadate also
regulate gene expression in a manner similar to insulin. In streptozotocin induced
diabetic animals, vanadate increases pancreatic amylase mRNA (Johnson et al),
phosphofructokinase and fructose-2,6-bisphosphatase mRNA (Inoue et al) and Glut 1
mRNA (Mountjoy & Flier) and inhibits phosphoenolcarboxykinase, pyruvate kinase
(Brichard et al and Valera et al). Vanadate inhibits the expression of PEPCK gene
(Bosch et al), while inducing the expression of pyruvate kinase and glucokinase genes
(Miralpeix et al). Selenate also normalises mRNA levels of G6PDH and FAS in STZ
induced diabetic rats (Berg et al) and rat primary hepatocytes (Stapleton et al).
Objective of the Study
The objective of my research project was to determine which proteins of the
insulin signal transduction pathway were necessary and in what sequence, in order
activate of the G6PDH gene expression. Since the insulin response may be tissue
specific, that is different proteins are involved in different sequences in different
tissues, it was of interest to map out the pathway in primary rat hepatocytes, which are
an excellent model for the primary target of insulin action, the liver. I have extensively
studied the signal mechanism involved in the mimetic action to determine if the
mimetics generated a cascade similar to insulin for the activation of G6PDH gene
expression.
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CHAPTER II
MATERIALS AND METHODS
Cell Culture, Maintenance and Processing
Hepatocyte Isolation and Maintenance
Hepatocytes were isolated from male Sprague-Dawley rats by the
hyaluronidase (Sigma Chemical Co., St. Louis, MO), collagenase (Boehringer
Mannheim, Indianapolis, IN) perfusion method as described by Stapleton et al. Rats
were food-deprived 48 hours prior to isolation of hepatocytes. On the day of surgery,
rats were anesthetised with an intraperitoneal injection of 30-40 units of
pentobarbitol/Kg body weight. The liver was perfused in situ, excised and forced
through 4 layers of sterile gauze to collect cells. The cells were washed 3 times with
Waymouth's MB 752/1 (Gibco, Grand Island, NY) medium containing bovine serum
albumin (BSA). Cell viability was checked by brilliant blue die exclusion method.
Cells with an average viability of greater than 80% were plated on sterile 60mm
collagen coated plates falcon-3002 plates, to a confluency of 90%. After 3 hours of
incubation in 4ml of Waymouth's MB 752/1 medium containing 0.5% BSA, the cells
were washed with BSA free Waymouth's medium and resuspended in the same.
Hepatocytes were maintained at 37°C in a humidified atmosphere of 5% CO2 and 95%
air.
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Cell Treatment
Cell Stimulation
Cells were stimulated with either 80nM insulin (a gift from Eli Lilly) for 5
minutes, with 500µM sodium selenate for 3 hours, or with 500uM sodium vanadate
(pH 6) for 3 hours.
Inhibitor Usage
Cells were pretreated with either l00nM wortmannin (Eli Lilly Inc.) for 3
hours, or with 50µM LY 294002 (Biomol) or 50µM B 581 (Biomol) for 30 minutes,
or with 20µM PD 098059 (Parke-Davis) or lO0nM rapamycin (Sigma Chemicals) for
1 hour prior to stimulation with either insulin or mimetics. (The concentrations and
incubation times were obtained from literature.)
Cell Harvest
Cells were treated with either insulin, selenate or vanadate and pretreated with
inhibitors as described. Two plates were used per condition for all treatments. Cell
processing was carried out at 4°C or on ice. Cells were lysed in the respective lysis
buffers as described in the individual assay procedures. All the cells were scraped into
the buffer and centrifuged to collect the extranuclear extracts. Extracts from two
plates of the same condition were pooled, flash frozen and stored at -20°C until further
use.
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Protein and Enzyme Assay Procedures
PI 3-Kinase Assay
PI 3-Kinase assay was carried out as described before by Serunian and Auger,
with a few modifications. Each plate of hepatocytes was first washed twice in 5ml
washing buffer containing 20mM Tris, pH 7.5, 137mM NaCl, l mM MgCh, l mM
CaCh and 100µM vanadate. Cells from each plate were then treated with 500µ1 of
extraction solution containing 10% glycerol, 1% Tween-40, lmM PMSF, 0. lmg/ml
aprotinin and 1µg/ml leupeptin for 20 minutes with rocking at 4°C. Cells were scraped
in the same solution, centrifuged and the extracts were collected as described
previously. For the assay, PI 3-Kinase was immunoprecipitated from the cell extracts
by incubating with 5µ1 of 1:2 diluted anti PI 3-Kinase, N-SH2 region antibody (anti
rat, monoclonal) (Upstate Biotrchnology, Inc.) per 200-400µg total protein, at 4°C
overnight. Protein-A agarose beads (Gibco-BRL) were first incubated for 30 minutes
in IOmM Tris buffer containing 1% BSA and subsequently washed 3 times with water.
The beads were resuspended in phosphate buffered saline (PBS) containing 2% azide
to give a 50%slurry. 50µ1 of the agarose slurry was added to the immunocomplex and
the mixture was incubated at 4°C for two hours to precipitate the complex. The
precipitate was washed 3 times with PBS containing 1% Tween-40 and I00µm
vanadate, followed by 3 washings with IO0mM Tris buffer, pH 7.5 containing 500mM
LiCl and finally two washings with l0mM Tris, pH 7.5, containing lO0mM NaCl,
1mM EDTA and 100µM vanadate. The precipitate was suspended in 50µ1 of the last
wash solution. The substrate, phosphatidylinositol (Sigma Chemical Co.) was prepared
by first dissolving the solid lipid in chloroform which was then evaporated under
nitrogen. The lipid was first resuspended in a solution of l0mM HEPES, pH 7.5,
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containing l rnM EGTA to give a final concentration of 2µg/ul and sonicated for 10
minutes by pulsing at a high speed.

For assaying the enzyme activity, 10µ1 of

sonicated substrate and 10µl of 100rnM MgC12 was added to the immunocomplex.
The kinase reaction was initiated by adding 440µM ATP (Sigma Chemical CO.)
containing 30uCi ofy-32P ATP (Dupont-NEN, MA) and l 0rnM MgCh. The reaction
mixture was incubated at 22°C for 10 minutes after which the reaction was stopped by
adding 20µ1 of 8N HCl. The lipid products were extracted by adding 160µ1 of
chloroform:methanol (1:1) mixture and then separated by thin layer chromatography.
An aliqout of the organic phase was spotted on a 2mm silica gel plate coated with 2%
potassium oxalate and subjected to thin layer chromatography.

The plates were

developed using chloroform, methanol, water and ammonium hydroxide in a
proportion of 60:47:11.3:2. The plates were exposed to X-ray film for vizualising the
spots which were further quantitated by scintillation counting.
Western Analysis
Association of PI 3-Kinase with IRS- I was analysed by following the dual
immunoprecipitation method.

PI 3-Kinase was immunoprecipitated from the cell

extracts as described in PI 3-Kinase assay protocol. The immunocomplex obtained by
incubating the enzyme+ antibody mixture with protein -A agarose beads was washed
with PBS and suspended in 50µ1 ofLaemmli sample buffer and subsequently subjected
to SDS-PAGE in a 8% acrylamide gel. Electrophoresis was carried out at l00mV for
2 hours after which the proteins were transferred to a PVDF membrane using the
directions provided by the manufacturer of the apparatus, NOVEX. The membrane
was blocked overnight in 50ml. of blocking buffer containing 5% milk in Tris Buffered
Saline containing 1% Tween-20 (TBST). It was then incubated with the primary
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antibody (1: 2000 dilution), anti IRS-1, carboxy terminal, anti rabbit, polyclonal
(Upstate Biotachnology) for 1 hour after which the gel was washed 3 times with
TBST.

Secondary antibody (anti-rabbit) conjugated to horse raddish peroxidase

(UBI) was added to the membrane (1 :2500 dilution) after which the gel was washed
again with TBST.

The reactive bands were detected using enhanced

chemiluminescence detecting system purchased from Amersham.
The association of PI 3-Kinase with Akt was checked usmg the same
procedure except Akt was immunoprecipitated from the cell lysate using anti-Akt,
carboxy terminal, anti-sheep, monoclonal antibody (Upstate Biotechnology) and the
primary antibody used was anti-PI 3-Kinase, N-SH2 region.
MAPK Assay
Map Kinase assay was performed either as described by Stapleton et al or as
indicated in the kit purchased from New England Biolabs. Detailed description of the
use of the kit will be outlined here. Cells were treated as described in the figure
captions and harvested after 48 hours of incubation. They were then lysed with 600µ1
of the cell lysis buffer provided in the kit. The extracts were sonicated 5 times for 5
seconds each, then centrifuged and stored as described above.

MAPK was

immunoprecipitated fom 200µ1 of the cell lysate containing 500-600µg total protein by
incubating with the phospho-MAPK antibody (1: 100 dilution) at 4°C overnight. The
immunocomplex was precipitated by incubating with 20µ1 of a 50% protein-A agarose
slurry in PBS, for 2 hours at 4°C. The pellet was washed twice with 500µ1 of cell lysis
buffer and then twice with 500µ1 of kinase buffer as mentioned in the kit. The pellet
was suspended in 50µ1 of kinase buffer supplemented with l00µM ATP and lµg Elk 1
fusion protein, suppplied in the kit.

After incubation for 30 minutes at room

temparature for 30minutes, the reaction was terminated by adding 25µ1 of 3X SDS
sample buffer. The sample was then boiled for 5 minutes, vortexed and centrifuged for
2 minutes. 20µ1 of the sample was subjected to SDS-PAGE as described by Laemmli,
at 100mV for 2 hours. Western analysis was carried out as described above using
phospho-specific elk-1 antibody provided in the kit. The antibody was diluted 1: 1000
in antibody dilution buffer (TBS containing 0.05% tween 20 and 5% BSA). Proteins
were detected using phototope-HRP western detection kit provided by the
manufacturer. Kinase activity was quantitated using scanning densitometry.
S6Kinase Assay
S6Kinase assay was performed using the S6K assay kit and following the
directions supplied by the manufacturer (Upstate Biotechnologies, Inc).

5µg of

S6Kinase antibody was first incubated with 100µ1 of protein-A agarose slurry
previously washed in PBS, for 30 minutes at 4°C. The beads were then washed with
Buffer A (50mM Tris, pH7.5, lmM EDTA, 0.5mM sodium orthovanadate, 0.1% B
mercaptoethanol, 1% triton X-100, 50mM NaF, 5mM sodium pyrophosphate, l0mM
sodium glycerophosphste, 0.1mM PMSF, 1µg/ml each of leupeptin and aprotinin and
resuspended in 100µ1 of buffer A. 75 µI of cell lysate containing 200-300 µg of total
protein was added to the beads and the reaction mixture was incubated for 2 hours at
4°C. The immunoprecipitate was washed with 500µ1 of buffer A containing 0.5M
NaCl, and then with buffer A alone, followed by a wash with the assay buffer (20mM
MOPS, pH 7.2, 25mM B-glycerophosphate, 5mM EGTA,

lmM sodium

orthovanadate and lmM DTT). Kinase reaction was carried out on the beads by
adding 10µ1 of assay buffer, 10µ1 of substrate cocktail ( substrate peptide in assay
buffer), 10µ1 of inhibitor cocktail and 10µ1 of ATP containing 30 µCi of y-32PATP.
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All reagents were provided in the kit. The reaction was allowed to continue for 10
minutes at room temparature. The beads were spun down and an aliqout of the
supernatant was spotted on phosphocellulose paper. Any non-bound radioactivity was
washed away by washing the assay squares with phosphoric acid and consequently
with acetone. The radioactivity incorporated into the product was qauntitated by
scintillation counting.

Appropriate controls as described in the kit were used to

correct for background counts.
Protein Estimation
Total protein concentration of cell extracts was determined by the method of
Lowry et al using BSA as the standard protein. Protein values were expressed as
µg/µl.

Statistical Analysis
Statistical significance was tested by the I-tail t test and all results, expressed
as+/- standard deviations of the mean, are significant at p < 0.05.
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CHAPTER III
RESULTS
Insulin response is a result of a series of phosphorylation events. To define the
pathway necessary for the activation of a specific response, activation of G6PDH gene
expression, we used inhibitors of certain signal proteins and analysed their effect on
insulin signal transduction in primary rat hepatocytes. The inhibition of the signal
proteins was then correlated to the effect of inhibitors on gene expression to determine
the necessity of a signal/protein in the cascade.
Insulin Induced Stimulation of PI3K is Sensitive to Wortmannin and LY 294002
PI3K, an enzyme involved in the regulation of metabolic and mitogenic
regulation in respnse to insulin and other growth factors (Kapellar et al), is known to
be inhibited by wortmannin and LY 294002. As shown in Figure 4, incubation of
primary rat hepatocytes with insulin showed a 7-10 fold induction in PI3K activity
which was sensitive to both LY 294002 and wortmannin. In the presence of either of
the two inhibitors, insulin induction of PI3K was completely blocked.
S6Kinase Activity
S6K is a downstream target of PI3K (Weng et al).

Rapamycin, an

immunosuppresant blocks the PDGF and insulin induced stimulation of S6K in a
variety of cell types including adipocytes and fibroblasts.

Since the

effect of

rapamycin in primary rat hepatocytes has not been studied, we analysed the activity of
S6K in response to insulin in the presence and absence of rapamycin. Our results show
19
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that insulin induced stimulation of S K activity is only partially inhibited by rapamycin
(Figure 5).

This suggests the involvement of a rapamycin insensitive pathway

mediated by another signal protein that transmits the signal from PBK to S6K.
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Figure 4. PD Kinase Activity. Primary rat hepatocytes were pretreated with either
(lO0n.M) wortmannin for 3 hours or 50µM LY 294002 for 30 minutes prior
to stimulation by 80nM insulin for 5 minutes_. n=5.
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Figure 5.

Insulin Induced S6Kinase Activity is Partially Inhibited by Rapamycin.
Hepatocytes were incubated with 1 00nM Rapamycin for 1 hour prior to
stimulation with 80rM insulin for 5 minutes.
Akt is a Direct Target of PBK

Akt has been shown to be a candidate for mediating the effects of PBK on
downstream processes since it is shown to be a direct target of PBK and can stimulate
S6K activity (Burgering et al). Insulin stimulation of Akt requires its association with
the i-SH2 region of PBK (Kohn et al).

To determine whether activated PBK

associates with Akt in primary rat hepatocyes, we carried out a double immunoblot
and western analysis on cells stimulated by insulin in the presence or absence of PBK

inhibitors. As shown in the picture of the electrograph, the dark band seen in insulin
stimulated cells denotes PBK associaion with Akt. Our results show that insulin
induced PBK does bind to Akt and interestingly, the inhibitors of PBK activation,
inhibit this insulin induced association (Figure 6). Little or no association is observed
in the control cells that have not been stimulated �y insulin.
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294002.
Figure 6. Insulin and Selenate Stimulate Association of PI 3-K With Akt. Cells were
treated as described for PI 3-K assay. The dark band seen with insulin
treatment represents the association of PI 3-K with Akt.
MAPK Activity
MAPK, being a serine/threonine phosphorylating agent could also potentially
stimulate S6K activity. The effect of the inhibitors of MAPK pathway, PD 098059,
which inhibits MEK and B581 which inhibits RAS farnesylation, has not been
determined in primary rat hepatocytes.

As shown in Figure 7, in primary rat

hepatocytes, MAPK activation is definitely RAS dependent since B581 completely
inhibited the insulin induced 2-3 fold stimulation of MAPK. Interestingly, PD 098059
only partially blocked the insulin induction of MAPK. Pl3K has been known to
stimulate MAPK activity in response to insulin in adipocytes (Suga et al).

We
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observed that the insulin induced MAPK activity was not inhibited by wortmannin
(Figure 7). Therefore we conclude that in this system, PI3K is not involved in MAPK
stimulation.
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*=significant stimulation. **=significant inhibition at p < 0.05.
Figure 7. Insulin Induced MAPK Activity is Dependent on RAS and l\1EK But Not
on PI 3-K. Primary rat hepatocytes were incubated with 80nM i�sulin either
in the presence or absence of20µM PD 098059 for 1 hour or 50µM B 581
for 30 minutes or 250nM wortmannin for 3 hours. n = 3.
Correlating the above studies with the effect of inhibitors on insulin induced
stimulation of G6PDH gene expression as studied by my collegue Sanjay Jivraj, we
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show that the pathway utilized by insulin is the IRS-l/Pl3K/S6K pathway and not the
RAS/RAF/MAPK pathway.
Insulin Mimetics Utilize a Different Pathway for Signal Transduction
Our laboratory has previously shown that insulin mimetics such as vanadium
and seleniuim also induce G6PDH enzyme activity and mRNA levels (Berg et al). To
determine whether the mimetics followed the same sequence of events as insulin in the
cytoplasm to bring about the final nuclear response in primary rat hepatocytes in
culture, we carried out inhibition studies on either selenium or vanadium stimulated
cells in a manner similar to the studies done on insulin stimulated cells.
Selenium induces phosphorylation of the insulin receptor and IRS-I (Stapleton
et al). As shown in Figure 8, Se also stimulates PBK but vanadium does not. To
determine if Se stimulation of PBK requires the association with IRS-1 similar to
insulin, we carried out western analysis.
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Figure 8. Selenium Does Not Induce Association ofIRS-1 and PI 3-K. Cells were
treated as described for PI 3-K assay. n = 3. The dark band representing
IRS-I seen with insulin stimulation is absent in Se treated cells.
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Figure 9. PI 3-K Activity is Stimulated by Se But Not Vanadate. Cells were
pretreated with inhibitors as described in the PI 3-K assay, prior to
stimulation with either 500µM selenate or vanadate for 3 hours. n=3.
The actions of Se, downstream of PBK are also different from insulin since it
does not stimulate S6K activity (Figure 10). Se activated PBK did associate with Akt
significantly more than the control levels but not as strongly as insulin (Figure 6). This
association was also blocked similarly to insulin in the presence of wortmannin.
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Legend. NA = No Addition, Se = selenate, R = Rapamycin.
Figure 10. Se Does Not Stimulate S6K Activity. Hepatocytes were pretreated with
1 00nM Rapamycin for 1 hour prior to stimulation with 500µM selenate for
3 hours. n = 4.
The 3-4 fold stimulation of MAPK activity in response to Se in primary rat
hepatocytes as shown in Figure 11, is comparable to that of insulin since the
stimulation of MAPK by Se is completely inhibited by B 581 but only partially
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inhibited by PD 098059. Contrary to results obtained with either Se or insulin, the
vanadium stimulated MAPK activity was neither significantly inhibited by PD 098059,
nor was it completely inhibited by B581 suggesting that vanadium stimulates MAPK in
a manner different from insulin or Se.
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Figure 11. MAPK Activity is Stimulated by Insullin Mimetics. Cells were pretreated
with inhibitors as described for MAPK activation by insulin and
subsequently stimulated by 500�tM Se on V for 3 hours. n = 3.

CHAPTER IV
DISCUSSION
Insulin is responsible for modulating the activity of many proteins in a variety
of cell types. The precise molecular mechanisms responsible for all these changes have
not yet been fully identified.

The use of inhibitors has gained importance for

elucidating the mechanism of insulin signal transduction which brings about the final
cellular response.

Most studies using inhibitors have focused on their effects in

different cell types, some of which are not physiological targets of insulin, like
fibroblasts, and others like CHO IR cells which overexpress the insulin receptor. Liver
is a primary target of insulin action and hence primary rat hepatocytes in culture is an
efficient model to analyse the tissue specific effects of insulin.
Wortmannin, a fungal antibiotic, is well characterized as a PI3K inhibitor in
many cell types including adipocytes, myoblasts and CHO IR cells and has been used
extensively to analyse the requirement of PI3K for insulin induced metabolic and
mitogenic responses. A more specific inhibitor of PI3K, LY 294002 was used to prove
the obligatory role of PI3K for the insulin induced stimulation of DNA synthesis,
glucose transport and S6K activation in 3T3 Ll adipocytes (Cheatham et al). Our
results are consistent with these studies as these compounds are effective inhibitors of
the insulin induced stimulation of PI3K in primary ra:t hepatocytes in culture.
To study the mechanism by which PI3K propagates the stimulus to the
nucleus, we examined the role of S6K as a putative downstream target.

s6K is

necessary for the PI3K induced stimulation of DNA synthesis (Mcilroy et al) and
glyceraldehyde-3-phosphate dehydrogenase (O'Brien & Grammer).
28

S6K has been
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shown to be stimulated by phosphorylation which can occur by either of the two
mechanisms- either directly by PBK (Weng et al) or via Akt (Burgering & Coffer).
On phosphorylation, S6K activity is controlled by FRAP, a rapamycin sensitive protein.
On binding to FRAP, rapamycin impairs the phosphorylation of S6K on thr 229 and
389, thus inhibiting S6K activity (Sugiyama et al). We found that incubation of
primary rat hepatocytes with insulin in the presence of rapamycin only partially
inhibited S6K activity. It is possible that there might be a protein involved in insulin
signaling which is activated by PBK and can stimulate S6K in a rapamycin insensitive
manner. Dennis et al have postulated the existence of rapamycin insensitive kinase
kinases that differentially regulate the phosphorylation of threonine 229 and 389.
Other reports stating that S6K was not the downstream effector of PBK for the insulin
induced regulation of PEPCK (Sutherland et al), DNA synthesis (Withers et al) and
glucose transport (Finger et al) also suggest the presence of a parallel pathway which
diverges from PBK and mediates downstream events. Our results showing insulin
activated PBK directly associates with Akt are striking and indicate that Akt, a protein
that has currently gained importance as one of the downstream effectors of PBK, is
also utilized as such in primary rat hepatocytes. Since Akt can stimulate S6K activity,
it is an attractive candidate for explaining the dual control of insulin on S6K in primary
rat hepatocytes. The association between PBK and Akt is required for insulin induced
activation of Akt (Kohn et al). Akt can regulate PBK mediated effects like DNA
synthesis, regulation of glucose transport and activity of glycogen synthase kinase in
3T3 Ll adipocytes (Kohn et al) by a rapamycin insensitive pathway (Cross et al). It
would be interesting to study the correlation of Akt kinase activity with S6Kinase
activity to further substantiate the involvement of Akt in insulin signal transduction.
Since there are no known inhibitors to date that specifically inhibit the kinase activity

of Akt, it is dificult to state definitely the requirement of Akt for the rapamycin
insensitive stimulation of S6K by insulin.
We also analysed the effect of insulin on the stimulation of another important
protein in the signal transduction cascade, MAPK. MAPK is necessary for certain
mitogenic effects of insulin such as cellular proliferation and restoration of DNA
binding activity (Davis et al).

MAPK is activated in response to insulin by the

serine/threonine kinase activity of MEK which lies downstream of Ras and Raf We
used the inhibitor of MEK, PD 098059, which is known to completely inhibit MAPK
stimulation (Dudley et al). Our results obtained by incubating primary rat hepatocytes
with insulin and PD 098059 are not in agreement with previous studies which have
reported that insulin induced MAPK stimulation is completely inhibited by PD 098059.
Higher concentrations of PD 098059 did not were also ineffective in inhibiting MAPK
to basal levels (results not shown). In primary rat hepatocytes, the inhibitor of MEK
only partially inhibited the insulin stimulation of MAPK, suggesting that MAPK can be
stimulated by insulin via a MEK independent pathway. Insulin induced stimulation of
MEK itself is dependent on the activation of RAS. Recent reports have questioned the
necessity of RAS for activation of the MEK/MAPK pathway in metabolic cell types
such as adipocytes (Whitehurst et al). Using the inhibitor of RAS farnesylation, B
581, we show that, in primary rat hepatocytes which are primarily metabolic, insulin
induced MAPK activation is completely RAS dependent since B581 had a striking
effect on insulin stimulated MAPK activity. The results presented above indicate that
insulin induction of MAPK occurs by two mechanisms, both of which are RAS
dependent. Suga et al have postulated the involvement of PI3K in stimulation of
MAPK by insulin and EGF in 3T3 Ll adipocytes. We studied the effect of PI3K
inhibitors on MAPK. As shown in the results, insulin stimulated activity of MAPK was
not inhibited by wortmannin.

30

31

There have been other reports of "cross-talk" between the PBK and MAPK
branches of the insulin signal transduction cascade. Rodriguez-Viciana et al reported
that PBK was a direct target of RAS, while Hu et al showed that some processes
regulated by PBK in response to insulin, such as glucose transport, are RAS
dependent. In CHO IR cells, PBK activity is completely distinct from RAS activation
(Hara et al). To explore the issue of "cross-talk" and to determine if PBK was
downstream of RAS, we studied the effect ofB 581 on PBK and B581 did not inhibit
the insulin stimulated activation of PBK (results not shown). Thus our results indicate
that there is no "cross-talk" between PBK and RAS, with regards to insulin
stimulation.
The role of insulin induced phosphorylation events has been studied in detail
with regards to the regulation of key metabolic enzymes that control glucose
homeostasis, with PEPCK, the key enzyme in gluconeogenesis, being the most
extensively characterized. Insulin effects on lipid metabolism have been analysed with
respect to the regulatory enzyme, fatty acid synthase (FAS), which is exquisitely
controlled by insulin in adipocytes. However, few studies have been done on insulin
regulation of the pentose phosphate pathway. The regulatory enzyme of the pathway,
G6PDH is modulated by insulin in the liver (Kletzein et al) but the sequential pathway
of insulin signal transduction required for G6PDH gene induction has not been
outlined. Using well characterized inhibitors of insulin induced signaling proteins, as
described above, we have outlined some of the phosphorylation events in primary rat
hepatocytes that are necessary for the insulin induction of G6PDH.
These effects of inhibitors on insulin stimulation of G6PDH gene expression in
primary rat hepatocytes were independently characterized in our laboratory (Stapleton
et al, unpublished results).

Insulin stimulation of G6PDH gene expression was

completely inhibited by wortmannin and LY 294002 and significantly, by rapamycin.
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B581 and PD 098059, however, did not have any effect on the insulin induced
G6PDH gene expression. Insulin induced stimulation of the endogenous G6PDH
activity was also insensitive to B 581 and PD 098059 but was completely inhibited by
wortmannin, LY 294002 and rapamycin. We therefore conclude, that insulin induced
stimulation of G6PDH gene expression requires the activation of PBK and is also
dependent on the rapamycin sensitive induction of S6K. Our results are interesting
with regards to the involvement of S6K in gene transcription since other metabolic
processes such as regulation of PEPCK (Sutherland et al), glycogen synthesis and
glucose transport (Withers et al) have been shown to be S6K independent.
Our laboratory has previously shown that insulin mimetics mimic the actions of
insulin on the induction of G6PDH enzyme activity. Selenium and vanadate both
upregulate the endogenous activity of G6PDH as well as stimulated the expression of
the G6PDH gene as measured by increases in endogenous mRNA levels and G6PDH
promoter driven luciferase reporter activity. We have analysed the signal propagation
mechanism of selenium and vanadate to determine if they follow the same signal
transduction pathway as insulin. Results presented here show that selenium does, to a
certain extent, induce the proteins in a manner similar to insulin. Selenium stimulates
the phosphorylation of insulin receptor, IRS-1 and activates MAPK as shown by
Stapleton et al. It is interesting that unlike insulin, we did not observe the association
between PBK and IRS-1 in selenium stimulated cells, although selenium does
stimulate PBK activity. One possibility is that, selenium being a potent stimulator of
tyrosine phosphorylation (Stapleton et al), it also phosphorylates other cell surface
recepters like the receptor for PDGF and EGF which can lead to the direct activation
of PBK (Kapellar & Cantley).

Selenium differed from insulin in activating the

proteins downstream of PBK as it failed to induce activation of S6K.

Selenium

induced association of PBK and Akt is also much weaker than that induced by insulin,

although stimulation ofPBK is similar. The mechanism by which selenium stimulates
MAPK may be similar to insulin since PD 098059 and B 581 both inhibit the selenium
stimulated MAPK activity.
Vanadium did not appear to be a true insulin mimetic with regard to activation
of signal proteins. In our model, vanadate did not induce the activation of PBK or
S6K. Vanadate induced stimulation ofMAPK is also MEK independent in primary rat
hepatocytes and is in agreement with previous studies by Band et al using
bisperoxovanadium 1,10-phenanthroline. Vanadate, a potent phosphatase inhibitor
may activate MAPK by inhibiting a specific tyrosine, threonine phosphatase that has
the potential to downregulate MAPK. Unlike MAPK, the activity of PBK is not
modulated by its phosphorylation status, and this may explain the reason for the
inability ofvanadate to stimulate PBK.
From the results presented here and the results obtained with insulin induction
of G6PDH gene expression, as studied by Sanjay Jivraj, we conclude that insulin
stimulation ofthe G6PDH gene expression requires the IRS-1/PI3K/S6K pathway and
not the RAS/RAF/MAPK pathway and the mimetics, selenium and vanadate mediate
their signals differently than insulin.
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